Russia’s Sputnik vaccine shows 91% efficacy in clinical trials
Lancet peer review confirms performance of country’s flagship two-shot jab
Full Article
Russia’s Sputnik vaccine shows 91% efficacy in clinical trials
FT.com
0 shares
1 views
You might like
Related news coverage
Russia's Sputnik V vaccine has 92% efficacy in trial
Trials with 20,000 volunteers show the vaccine gives a high level of protection against Covid-19.
BBC News